Immunosuppressive Therapy in Myelodysplastic Syndromes Is Still Alive
Cyclosporine Combined with Levamisole for Lower-Risk Myelodysplastic Syndromes
Atovaquone for Prophylaxis of Toxoplasmosis after Allogeneic Hematopoietic Stem Cell Transplantation
Epstein-Barr Virus-Positive Pyothorax-Associated Lymphoma Arising from a Posttraumatic Empyema
Lymphoproliferative Disorders in Patients with Chronic Myeloid Leukemia: A Single-Center Case Series
Rituximab in Thrombotic Thrombocytopenic Purpura: Medical and Financial Benefits
A 14-Year Experience in the Management of Patients with Acquired Immune Thrombotic Thrombocytopenic Purpura in Northern Israel
The Prevalence and Biochemical Profiles of EDTA-Dependent Pseudothrombocytopenia in a Generally Healthy Population
Two Cases of Successful Autologous Hematopoietic Stem Cell Harvest after Treatment with Brentuximab Vedotin
Thalassemia Major: Who Is Afraid of Serum Ferritin below 500 μg/l?
What Is the Role of Rituximab in Nodular Lymphocyte-Predominant Hodgkin Lymphoma?
Can Rituximab Improve the Outcome of Patients with Nodular Lymphocyte-Predominant Hodgkin's Lymphoma?
A Novel Homozygous c.800C>G Substitution in GP1BA Exon 2 in a Kuwaiti Family with Bernard-Soulier Syndrome